Peter Hoang | President and CEO |
Anthony Kim | CFO |
Mythili Koneru | Chief Medical Officer |
Juan Vera | Chief Development Officer |
Joseph Catanzaro | Piper Sandler |
Kristen Kluska | Cantor Fitzgerald |
Matthew Biegler | Oppenheimer |
Tony Butler | ROTH Capital |
Hello and welcome to the Marker Therapeutics' First Quarter 2021 Operating and Financial Results Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded. It is now my pleasure to turn the call over to CFO, Tony Kim. Please go ahead, sir.